A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies

Brain

Volumn 134, Issue 9, 2011, Pages 2548-2564

  Lashley, Tammaryn ^a   Rohrer, Jonathan D ^a   Bandopadhyay, Rina ^b   Fry, Charles ^a   Ahmed, Zeshan ^a   Isaacs, Adrian M ^a   Brelstaff, Jack H ^a,b   Borroni, Barbara ^a   Warren, Jason D ^a   Troakes, Claire ^c   King, Andrew ^d   Al Saraj, Safa ^d   Newcombe, Jia ^a   Quinn, Niall ^e   Ostergaard, Karen ^f   Schrøder, Henrik Daa ^f   Bojsen Møller, Marie ^g   Braendgaard, Hans ^g   Fox, Nick C ^a   Rossor, Martin N ^a   Lees, Andrew J ^a,b   Holton, Janice L ^a   Revesz, Tamas ^a   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d KING S COLLEGE HOSPITAL   (United Kingdom)

^e NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

biochemistry; clinical presentation; frontotemporal lobar degeneration; FUS; neuropathology

Indexed keywords

DNA BINDING PROTEIN; TAU PROTEIN; UBIQUITIN;

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; COMPARATIVE STUDY; CONTROLLED STUDY; EXTRAPYRAMIDAL SYNDROME; FEMALE; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTONEURON; MOTOR NEURON DISEASE; NEUROIMAGING; NEURONAL INTERMEDIATE FILAMENT INCLUSION DISEASE; ONSET AGE; PATHOLOGY; PRIORITY JOURNAL; TEMPORAL LOBECTOMY;

EID: 80052942395     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr160     Document Type: Article

References (40)

1. Aman P, Panagopoulos I, Lassen C, Fioretos T, Mencinger M, Toresson H, et al. Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics 1996; 37: 1-8. (Pubitemid 26341827)
2. Andersson MK, Stahlberg A, Arvidsson Y, Olofsson A, Semb H, Stenman G, et al. The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol 2008; 9: 37.
3. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351: 602-11. (Pubitemid 44708852)
4. Armstrong RA, Gearing M, Bigio EH, Cruz-Sanchez FF, Duyckaerts C, Mackenzie IR, et al. The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease. Acta Neuropathol 2011; 121: 219-28.
5. Baechtold H, Kuroda M, Sok J, Ron D, Lopez BS, Akhmedov AT. Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation. J Biol Chem 1999; 274: 34337-42. (Pubitemid 129511776)
6. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in progranulin cause tau-negative fron-totemporal dementia linked to chromosome 17. Nature, 2006; 442, 916-9. (Pubitemid 44285946)
7. Belly A, Moreau-Gachelin F, Sadoul R, Goldberg Y. Delocalization of the multifunctional RNA splicing factor TLS/FUS in hippocampal neurones: exclusion from the nucleus and accumulation in dendritic granules and spine heads. Neurosci Lett 2005; 379: 152-7. (Pubitemid 40544525)
8. Bertrand P, Akhmedov AT, Delacote F, Durrbach A, Lopez BS. Human POMp75 is identified as the pro-oncoprotein TLS/FUS: both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferation. Oncogene 1999; 18: 4515-21. (Pubitemid 29396659)
9. Buratti E, Baralle FE. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci 2008; 13: 867-78. (Pubitemid 351594732)
10. Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, et al. Neuropathologic diagnostic and nosologic criteria for frontotem-poral lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 2007; 114: 5-22. (Pubitemid 47029055)
11. Cairns NJ, Zhukareva V, Uryu K, Zhang B, Bigio E, Mackenzie IR, et al. Alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Am J Pathol 2004; 164: 2153-61. (Pubitemid 38669362)
12. Crozat A, Aman P, Mandahl N, Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 1993; 363: 640-4. (Pubitemid 23227627)
13. Cruts M, Kumar-Singh S, Van BC. Progranulin mutations in ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Curr Alzheimer Res 2006; 3: 485-91. (Pubitemid 46066424)
14. Davidson Y, Kelley T, Mackenzie IR, Pickering-Brown S, Du PD, Neary D, et al. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 2007; 113: 521-33. (Pubitemid 46672598)
15. Giordana MT, Piccinini M, Grifoni S, De MG, Vercellino M, Magistrello M, et al. TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis. Brain Pathol 2010; 20: 351-60.
16. Holton JL, Ghiso J, Lashley T, Rostagno A, Guerin CJ, Gibb G, et al. Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol 2001; 158: 515-26. (Pubitemid 32158612)
17. Huang C, Xia PY, Zhou H. Sustained expression of TDP-43 and FUS in motor neurons in rodent's lifetime. Int J Biol Sci 2010; 6: 396-406.
18. Josephs KA, Holton JL, Rossor MN, Braendgaard H, Ozawa T, Fox NC, et al. Neurofilament inclusion body disease: a new proteinopathy? Brain 2003; 126: 2291-303. (Pubitemid 37432372)
19. Josephs KA, Holton JL, Rossor MN, Godbolt AK, Ozawa T, Strand K, et al. Frontotemporal lobar degeneration and ubiquitin immunohisto-chemistry. Neuropathol Appl Neurobiol 2004; 30: 369-73. (Pubitemid 39120298)
20. Kwiatkowski TJ Jr, Bosco DA, LeClerc AL, Tamrazian E, Vanderburg CR, Russ C, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009; 323: 1205-8.
21. Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, Berns A, et al. Simplified mammalian DNA isolation procedure. Nucleic Acids Res 1991; 19: 4293.
22. Loy CT, McCusker E, Kril JJ, Kwok JB, Brooks WS, McCann H, et al. Very early-onset frontotemporal dementia with no family history predicts underlying fused in sarcoma pathology. Brain 2010; 133: e158.
23. Mackenzie IR, Baborie A, Pickering-Brown S, Du PD, Jaros E, Perry RH, et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol 2006; 112: 539-49. (Pubitemid 44550678)
24. Mackenzie IR, Munoz DG, Kusaka H, Yokota O, Ishihara K, Roeber S, et al. Distinct pathological subtypes of FTLD-FUS. Acta Neuropathol 2011; 121: 207-18.
25. Mori F, Tanji K, Zhang HX, Nishihira Y, Tan CF, Takahashi H, et al. Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol 2008; 116: 193-203.
26. Munoz DG, Neumann M, Kusaka H, Yokota O, Ishihara K, Terada S, et al. FUS pathology in basophilic inclusion body disease. Acta Neuropathol 2009; 118: 617-27.
27. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-54.
28. Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IR, et al. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 2009a; 132: 2922-31.
29. Neumann M, Roeber S, Kretzschmar HA, Rademakers R, Baker M, Mackenzie IR. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol 2009b; 118: 605-16.
30. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-33. (Pubitemid 44547757)
31. Paviour DC, Lees AJ, Josephs KA, Ozawa T, Ganguly M, Strand C, et al. Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy. Brain 2004; 127 (Pt 11): 2441-51. (Pubitemid 39472972)
32. Perrotti D, Bonatti S, Trotta R, Martinez R, Skorski T, Salomoni P, et al. TLS/FUS, a pro-oncogene involved in multiple chromosomal transloca-tions, is a novel regulator of BCR/ABL-mediated leukemogenesis. EMBO J 1998; 17: 4442-55. (Pubitemid 28362633)
33. Prasad DD, Ouchida M, Lee L, Rao VN, Reddy ES. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene 1994; 9: 3717-29. (Pubitemid 24359413)
34. Roeber S, Mackenzie IR, Kretzschmar HA, Neumann M. TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD. Acta Neuropathol 2008; 116: 147-57.
35. Rohrer JD, Guerreiro R, Vandrovcova J, Uphill J, Reiman D, Beck J, et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology 2009; 73: 1451-6.
36. Rohrer JD, Lashley T, Holton J, Revesz T, Urwin H, Isaacs AM, et al. The clinical and neuroanatomical phenotype of FUS associated frontotem-poral lobar degeneration. J Neurol Neurosurg Psychiatry 2010. July 16. [Epub ahead of print] doi:10.1136/jnnp.2010.214437.
37. Urwin H, Josephs KA, Rohrer JD, Mackenzie IR, Neumann M, Authier A, et al. FUS pathology defines the majority of tau-and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol 2010; 120: 33-41.
38. Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009; 323: 1208-11.
39. Yang S, Warraich ST, Nicholson GA, Blair IP. Fused in sarcoma/translocated in liposarcoma: a multifunctional DNA/RNA binding protein. Int J Biochem Cell Biol 2010; 42: 1408-11.
40. Zinszner H, Sok J, Immanuel D, Yin Y, Ron D. TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J Cell Sci 1997; 110 (Pt 15): 1741-50. (Pubitemid 27352853)